Sartorius Stedim Biotech SA (DIM) - Total Assets

Latest as of March 2026: €8.19 Billion EUR ≈ $9.57 Billion USD

Based on the latest financial reports, Sartorius Stedim Biotech SA (DIM) holds total assets worth €8.19 Billion EUR (≈ $9.57 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check DIM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Sartorius Stedim Biotech SA - Total Assets Trend (2005–2025)

This chart illustrates how Sartorius Stedim Biotech SA's total assets have evolved over time, based on quarterly financial data. Explore Sartorius Stedim Biotech SA strategic investment ratio to see how much of total assets are deployed in long-term investments.

Sartorius Stedim Biotech SA - Asset Composition Analysis

Current Asset Composition (December 2025)

Sartorius Stedim Biotech SA's total assets of €8.19 Billion consist of 18.0% current assets and 82.0% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	5.3%
Accounts Receivable	€227.30 Million	2.8%
Inventory	€690.90 Million	8.6%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€1.54 Billion	19.2%
Goodwill	€2.88 Billion	36.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Sartorius Stedim Biotech SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Sartorius Stedim Biotech SA worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Sartorius Stedim Biotech SA's current assets represent 18.0% of total assets in 2025, a decrease from 53.2% in 2005.
Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 2.7% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 8.0% in 2005.
Asset Diversification: The largest asset category is goodwill at 36.0% of total assets.

Sartorius Stedim Biotech SA Competitors by Total Assets

Key competitors of Sartorius Stedim Biotech SA based on total assets are shown below.

Company	Country	Total Assets
Autek China Inc SHE:300595	China	CN¥6.40 Billion
QITIAN Technology Group Co Ltd SHE:300061	China	CN¥1.17 Billion
Caina Technology Co. Ltd. SHE:301122	China	CN¥2.24 Billion
IVF Hartmann Holding AG SW:VBSN	Switzerland	CHF180.92 Million
Dentium KO:145720	Korea	₩932.79 Billion
Nyxoah BR:NYXH	Belgium	€93.60 Million
DIO Corporation KQ:039840	Korea	₩332.33 Billion
Ansell Ltd AU:ANN	Australia	AU$3.33 Billion

Sartorius Stedim Biotech SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.03	1.85	1.58
Quick Ratio	0.58	1.14	0.82
Cash Ratio	0.00	0.00	0.00
Working Capital	€41.50 Million	€815.30 Million	€459.60 Million

Sartorius Stedim Biotech SA - Advanced Valuation Insights

This section examines the relationship between Sartorius Stedim Biotech SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.87
Latest Market Cap to Assets Ratio	1.99
Asset Growth Rate (YoY)	-2.9%
Total Assets	€8.02 Billion
Market Capitalization	$15.98 Billion USD

Valuation Analysis

Above Book Valuation: The market values Sartorius Stedim Biotech SA's assets above their book value (1.99x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: Sartorius Stedim Biotech SA's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Sartorius Stedim Biotech SA (2005–2025)

The table below shows the annual total assets of Sartorius Stedim Biotech SA from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	€8.02 Billion ≈ $9.37 Billion	-2.89%
2024-12-31	€8.26 Billion ≈ $9.65 Billion	+6.67%
2023-12-31	€7.74 Billion ≈ $9.05 Billion	+52.80%
2022-12-31	€5.07 Billion ≈ $5.92 Billion	+28.20%
2021-12-31	€3.95 Billion ≈ $4.62 Billion	+28.73%
2020-12-31	€3.07 Billion ≈ $3.59 Billion	+68.61%
2019-12-31	€1.82 Billion ≈ $2.13 Billion	+15.84%
2018-12-31	€1.57 Billion ≈ $1.84 Billion	+11.93%
2017-12-31	€1.40 Billion ≈ $1.64 Billion	+17.40%
2016-12-31	€1.20 Billion ≈ $1.40 Billion	+12.17%
2015-12-31	€1.07 Billion ≈ $1.25 Billion	+17.58%
2014-12-31	€906.76 Million ≈ $1.06 Billion	+4.08%
2013-12-31	€871.23 Million ≈ $1.02 Billion	+9.74%
2012-12-31	€793.87 Million ≈ $928.11 Million	+10.16%
2011-12-31	€720.66 Million ≈ $842.53 Million	+9.80%
2010-12-31	€656.34 Million ≈ $767.32 Million	-1.73%
2009-12-31	€667.86 Million ≈ $780.80 Million	+2.38%
2008-12-31	€652.34 Million ≈ $762.66 Million	+1.81%
2007-12-31	€640.72 Million ≈ $749.07 Million	+69.80%
2006-12-31	€377.34 Million ≈ $441.15 Million	+4.09%
2005-12-31	€362.53 Million ≈ $423.83 Million	--

About Sartorius Stedim Biotech SA

PA:DIM France Medical Instruments & Supplies

Market Cap

$20.07 Billion

€17.17 Billion EUR

Market Cap Rank

#1550 Global

#35 in France

Share Price

€176.50

Change (1 day)

+0.06%

52-Week Range

€151.50 - €223.00

All Time High

€542.33